New-onset paroxysmal atrial fibrillation: Is permanence inevitable?

American Heart Journal

Volumn 149, Issue 3, 2005, Pages 388-390

  Patton, Kristen K ^a   Page, Richard L ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ANTICOAGULATION; DISEASE ASSOCIATION; DISEASE COURSE; DRUG USE; EDITORIAL; ELECTROCARDIOGRAPHY; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK; RECURRENT DISEASE; THROMBOEMBOLISM;

EID: 17844385558     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2004.11.004     Document Type: Editorial

References (22)

1. S.L. Kopecky The natural history of lone atrial fibrillation. A population-based study over three decades N. Engl. J. Med. 317 1987 669 674
2. B.J. Gersh, and A. Solomon Lone atrial fibrillation: epidemiology and natural history Am. Heart J. 137 1999 592 595
3. C.R. Kerr Progression to chronic atrial fibrillation following the initial diagnosis of paroxysmal atrial fibrillation Am. Heart J. 149 2005 489 496
4. V. Fuster ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysiology Circulation 104 2001 2118 2150
5. E. Davidson Diagnosis and characteristics of lone atrial fibrillation Chest 95 1989 1048 1050
6. S. Levy Characterization of different subsets of atrial fibrillation in general practice in France: The ALFA Study Circulation 99 1999 3028 3035
7. E. Antman Therapy of refractory symptomatic atrial fibrillation and atrial flutter: a staged care approach with new antiarrhythmic drugs J. Am. Coll. Cardiol. 15 1990 698 707
8. E. Pritchett Management of atrial fibrillation N. Engl. J. Med. 326 1992 1264 1271
9. A.K. Bhandari Correlation of symptoms with occurrence of paroxysmal supraventricular tachycardia or atrial fibrillation: a transtelephonic monitoring study Am. Heart J. 124 1992 381 386
10. R.L. Page Asymptomatic or "silent" atrial fibrillation: frequency in untreated patients and patients receiving azimilide Circulation 107 2003 1141 1145
11. C.W. Israel, G. Gronefeld, and J.R. Ehrlich Long-term risk of recurrent atrial fibrillation as documented by an implantable monitoring device: implications for optimal patient care J. Am. Coll. Cardiol. 43 2004 47 52
12. M.C. Wijffels Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats Circulation 92 1995 1954 1968
13. L. Yue Ionic remodeling underlying action potential changes in a canine model of atrial fibrillation Circ. Res. 81 1997 512 525
14. A. Frustaci Histological substrate of atrial biopsies in patients with lone atrial fibrillation Circulation 96 1997 1180 1184
15. C.M. Guiraudon The pathology of drug resistant lone atrial fibrillation in eleven surgically treated patients J. Kingma N. Van Hernel K. Lie Atrial fibrillation: a treatable disease? 1992 Kluwer Academic Publishers Dordrecht 41 57
16. J. Ausma Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat Circulation 96 1997 3157 3163
17. R. Brugada Identification of a genetic locus for familial atrial fibrillation N. Engl. J. Med. 336 1997 905 911
18. P.T. Ellinor Locus for atrial fibrillation maps to chromosome 6q14-16 Circulation 107 2003 2880 2883
19. Y.-H. Chen KCNQ1 gain-of-function mutation in familial atrial fibrillation Science 299 2003 251 254
20. D.G. Wyse, and B.J. Gersh Atrial fibrillation: a perspective, thinking inside and outside the box Circulation 109 2004 3089 3095
21. O.D. Pedersen, H. Bagger, and L. Køber Trandolapril reduces the incidence of atrial fibrillation after acute myocardial infarction in patients with left ventricular dysfunction Circulation 100 1999 376 380
22. E. Vermes, J.-C. Tardif, and M.G. Bourassa Enalapril decreases the incidence of atrial fibrillation in patients with left ventricular dysfunction: insight from the studies of left ventricular dysfunction (SOLVD) trials Circulation 107 2003 2926 2931